ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
X-energy forms partnership with Talen Energy to assess Xe-100 deployment
X-energy announced Thursday that it has signed a letter of intent with Talen Energy to assess the deployment of X-energy’s Xe-100 reactor in Pennsylvania and throughout the market area of the PJM Interconnection regional transmission organization. That area, where the companies intend to explore the deployment of at least three four-unit Xe-100 power plants, includes several states in the eastern United States, from New Jersey to Illinois.
S.C. Prager
Fusion Science and Technology | Volume 27 | Number 3 | April 1995 | Pages 40-44
Overview Paper | doi.org/10.13182/FST95-A11947044
Articles are hosted by Taylor and Francis Online.
The reactor attributes of the compact, high beta RFP are as needed today as when the RFP was conceived. Confinement is a dominant scientific issue at present, In the past several years magnetic fluctuations have been shown experimentally to drive anomalous transport. From an understanding of the cause of transport, it is expected that flattening of the current density profile should suppress fluctuations and transport. Inductive current profile control has succeeded in reducing fluctuations, and doubling the energy and particle confinement times. For steady state current profile control, electrostatic current injection (dc helicity injection) is under preparation and rf current drive (fast wave and lower hybrid) has been shown to be feasible.